American Portfolios Advisors Ishares Tr Genomics Immunology Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, American Portfolios Advisors holds 664 shares of IDNA stock, worth $15,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
664
Holding current value
$15,272
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$25.77 - $34.57 $17,111 - $22,954
664 New
664 $17.5 Million
Q2 2021

Mar 22, 2023
SELL
$43.63 - $52.03 $12,609 - $15,036
-289 Reduced 43.52%
375 $19.5 Million
Q1 2021

Mar 22, 2023
SELL
$42.64 - $54.83 $12,322 - $15,845
-289 Reduced 43.52%
375 $17.1 Million
Q4 2020

Mar 22, 2023
SELL
$37.93 - $50.1 $10,961 - $14,478
-289 Reduced 43.52%
375 $17.2 Million
Q3 2020

Mar 22, 2023
SELL
$35.37 - $40.93 $13,758 - $15,921
-389 Reduced 58.58%
275 $10.7 Million
Q2 2020

Mar 24, 2023
BUY
$25.51 - $39.04 $90,279 - $138,162
3,539 Added 532.98%
4,203 $160 Million

Others Institutions Holding IDNA

# of Institutions
59
Shares Held
1.68M
Call Options Held
0
Put Options Held
0
View Full List

About ISHARES TR GENOMICS IMMUNOLOGY

IDNA Quotes by TradingView
  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email